Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 140 and 462 of CROT (Uniprot ID#Q9UKG9)|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 10% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-21650 targets COT in IHC (P) and WB applications and shows reactivity with Human and mouse samples.
The PA5-21650 immunogen is a recombinant fragment corresponding to a region within amino acids 140 and 462 of CROT (Uniprot ID#Q9UKG9).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
augmented in rheumatoid arthritis 2; cancer Osaka thyroid oncogene; cancer Osaka thyroid, oncogene; cot (cancer Osaka thyroid) oncogene; COT proto-oncogene serine/threonine-protein kinase; Ewing sarcoma transformant; mitogen activated protein kinase kinase kinase 8; mitogen-activated protein kinase kinase kinase 8; peroxisomal carnitine acyltransferase; peroxisomal carnitine O-octanoyltransferase; proto-oncogene c-Cot; proto-oncogene serine/threoine protein kinase; serine/threonine-protein kinase cot; tumor progression locus 2
AURA2; c-COT; COT; Cot/Tpl2; EST; ESTF; MAP3K8; MEKK8; Tpl-2; TPL2